vs

Side-by-side financial comparison of Gitlab Inc. (GTLB) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

Gitlab Inc. is the larger business by last-quarter revenue ($244.4M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). Gitlab Inc. runs the higher net margin — -3.4% vs -82.0%, a 78.6% gap on every dollar of revenue. On growth, Gitlab Inc. posted the faster year-over-year revenue change (24.6% vs -22.7%). Gitlab Inc. produced more free cash flow last quarter ($28.4M vs $-36.6M). Over the past eight quarters, Gitlab Inc.'s revenue compounded faster (22.1% CAGR vs -11.5%).

GitLab Inc. is an American company that operates and develops GitLab, an open-core DevOps software package that can develop, secure, and operate software. GitLab includes a distributed version control system based on Git, including features such as access control, bug tracking, software feature requests, task management, and wikis for every project, as well as snippets.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

GTLB vs PTCT — Head-to-Head

Bigger by revenue
GTLB
GTLB
1.5× larger
GTLB
$244.4M
$164.7M
PTCT
Growing faster (revenue YoY)
GTLB
GTLB
+47.4% gap
GTLB
24.6%
-22.7%
PTCT
Higher net margin
GTLB
GTLB
78.6% more per $
GTLB
-3.4%
-82.0%
PTCT
More free cash flow
GTLB
GTLB
$65.0M more FCF
GTLB
$28.4M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
GTLB
GTLB
Annualised
GTLB
22.1%
-11.5%
PTCT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
GTLB
GTLB
PTCT
PTCT
Revenue
$244.4M
$164.7M
Net Profit
$-8.3M
$-135.0M
Gross Margin
86.8%
Operating Margin
-5.1%
-43.3%
Net Margin
-3.4%
-82.0%
Revenue YoY
24.6%
-22.7%
Net Profit YoY
-128.0%
-104.8%
EPS (diluted)
$-0.05
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GTLB
GTLB
PTCT
PTCT
Q4 25
$244.4M
$164.7M
Q3 25
$236.0M
$211.0M
Q2 25
$214.5M
$178.9M
Q1 25
$211.4M
$1.2B
Q4 24
$196.0M
$213.2M
Q3 24
$182.6M
$196.8M
Q2 24
$169.2M
$186.7M
Q1 24
$163.8M
$210.1M
Net Profit
GTLB
GTLB
PTCT
PTCT
Q4 25
$-8.3M
$-135.0M
Q3 25
$-9.2M
$15.9M
Q2 25
$-35.9M
$-64.8M
Q1 25
$5.8M
$866.6M
Q4 24
$29.6M
$-65.9M
Q3 24
$12.9M
$-106.7M
Q2 24
$-54.6M
$-99.2M
Q1 24
$-36.5M
$-91.6M
Gross Margin
GTLB
GTLB
PTCT
PTCT
Q4 25
86.8%
Q3 25
87.9%
Q2 25
88.3%
Q1 25
89.2%
Q4 24
88.7%
Q3 24
88.3%
Q2 24
88.9%
Q1 24
90.2%
Operating Margin
GTLB
GTLB
PTCT
PTCT
Q4 25
-5.1%
-43.3%
Q3 25
-7.8%
1.4%
Q2 25
-16.1%
-19.5%
Q1 25
-9.1%
82.5%
Q4 24
-14.7%
-76.2%
Q3 24
-22.5%
-27.7%
Q2 24
-31.7%
-21.5%
Q1 24
-21.3%
-21.6%
Net Margin
GTLB
GTLB
PTCT
PTCT
Q4 25
-3.4%
-82.0%
Q3 25
-3.9%
7.5%
Q2 25
-16.7%
-36.3%
Q1 25
2.7%
73.7%
Q4 24
15.1%
-30.9%
Q3 24
7.1%
-54.2%
Q2 24
-32.3%
-53.1%
Q1 24
-22.3%
-43.6%
EPS (diluted)
GTLB
GTLB
PTCT
PTCT
Q4 25
$-0.05
$-1.63
Q3 25
$-0.06
$0.20
Q2 25
$-0.22
$-0.83
Q1 25
$0.05
$10.04
Q4 24
$0.18
$-0.85
Q3 24
$0.08
$-1.39
Q2 24
$-0.35
$-1.29
Q1 24
$-0.23
$-1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GTLB
GTLB
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$224.2M
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$922.7M
$-205.3M
Total Assets
$1.6B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GTLB
GTLB
PTCT
PTCT
Q4 25
$224.2M
$1.9B
Q3 25
$261.4M
$1.7B
Q2 25
$255.7M
$2.0B
Q1 25
$227.6M
$2.0B
Q4 24
$176.6M
$1.1B
Q3 24
$438.6M
$1.0B
Q2 24
$420.3M
$1.1B
Q1 24
$288.0M
$884.8M
Stockholders' Equity
GTLB
GTLB
PTCT
PTCT
Q4 25
$922.7M
$-205.3M
Q3 25
$866.6M
$-155.8M
Q2 25
$808.3M
$-206.5M
Q1 25
$775.9M
$-185.8M
Q4 24
$724.7M
$-1.1B
Q3 24
$642.8M
$-1.1B
Q2 24
$567.8M
$-980.2M
Q1 24
$571.2M
$-893.9M
Total Assets
GTLB
GTLB
PTCT
PTCT
Q4 25
$1.6B
$2.9B
Q3 25
$1.5B
$2.6B
Q2 25
$1.4B
$2.6B
Q1 25
$1.4B
$2.7B
Q4 24
$1.3B
$1.7B
Q3 24
$1.4B
$1.8B
Q2 24
$1.3B
$1.9B
Q1 24
$1.3B
$1.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GTLB
GTLB
PTCT
PTCT
Operating Cash FlowLast quarter
$31.4M
$-34.3M
Free Cash FlowOCF − Capex
$28.4M
$-36.6M
FCF MarginFCF / Revenue
11.6%
-22.3%
Capex IntensityCapex / Revenue
1.2%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$242.3M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GTLB
GTLB
PTCT
PTCT
Q4 25
$31.4M
$-34.3M
Q3 25
$49.4M
$-66.3M
Q2 25
$106.3M
$-58.3M
Q1 25
$63.2M
$870.1M
Q4 24
$-177.0M
$-30.0M
Q3 24
$11.7M
$-77.0M
Q2 24
$38.1M
$-71.5M
Q1 24
$24.9M
$70.8M
Free Cash Flow
GTLB
GTLB
PTCT
PTCT
Q4 25
$28.4M
$-36.6M
Q3 25
$46.5M
$-69.7M
Q2 25
$105.4M
$-59.6M
Q1 25
$62.1M
$868.4M
Q4 24
$-178.1M
$-33.8M
Q3 24
$10.8M
$-77.5M
Q2 24
$37.4M
$-78.8M
Q1 24
$24.5M
$61.2M
FCF Margin
GTLB
GTLB
PTCT
PTCT
Q4 25
11.6%
-22.3%
Q3 25
19.7%
-33.1%
Q2 25
49.1%
-33.3%
Q1 25
29.4%
73.8%
Q4 24
-90.8%
-15.8%
Q3 24
5.9%
-39.4%
Q2 24
22.1%
-42.2%
Q1 24
15.0%
29.1%
Capex Intensity
GTLB
GTLB
PTCT
PTCT
Q4 25
1.2%
1.4%
Q3 25
1.2%
1.6%
Q2 25
0.4%
0.7%
Q1 25
0.5%
0.1%
Q4 24
0.5%
1.8%
Q3 24
0.5%
0.3%
Q2 24
0.4%
4.0%
Q1 24
0.2%
4.6%
Cash Conversion
GTLB
GTLB
PTCT
PTCT
Q4 25
Q3 25
-4.17×
Q2 25
Q1 25
10.89×
1.00×
Q4 24
-5.99×
Q3 24
0.90×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GTLB
GTLB

Subscription And Circulation$146.4M60%
Subscription Software As A Service$76.9M31%
License$15.5M6%
Professional Services And Other$5.6M2%

PTCT
PTCT

Segment breakdown not available.

Related Comparisons